← Back to home
Comparison · Analytics

pharmaversesdtm vs Plotly

A side-by-side editorial comparison of pharmaversesdtm and Plotly — release velocity, themes, recent moves, and the top alternatives to consider.

pharmaversesdtm vs Plotly: at a glance

FeaturepharmaversesdtmPlotly
SectorAnalyticsAnalytics
Velocity score0.06.3
Sparks · 30d01
Top themespharmaverse, sdtm, cdisc, test-dataai-app-building, plotly-cloud, metered-billing, custom-domains
Last editorial update4d ago8h ago
WebsiteVisit →Visit →

What is pharmaversesdtm?

pharmaversesdtm is the test-data layer every pharmaverse package now builds against.

The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.

Read the full pharmaversesdtm trajectory →

What is Plotly?

Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.

Plotly ships on two tracks. Plotly Studio, the desktop AI app-builder, releases every one to two weeks and has spent v0.0.80 through v0.0.86 on credential handling, reasoning transparency, personalization and now the reliability of the agent session engine itself. Plotly Cloud is the louder track: since late May it has added viewer-seat pricing, domain verification, per-app compute modes with credit-metered billing, and customer-owned domains with managed TLS.

Read the full Plotly trajectory →

pharmaversesdtm vs Plotly: editorial side-by-side

P0.0

pharmaversesdtm is the test-data layer every pharmaverse package now builds against.

◆ Current state

The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.

◆ Where it's heading

Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.

◆ Prediction

New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.

P
Plotly
ANALYTICS
6.3

Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.

◆ Current state

Plotly ships on two tracks. Plotly Studio, the desktop AI app-builder, releases every one to two weeks and has spent v0.0.80 through v0.0.86 on credential handling, reasoning transparency, personalization and now the reliability of the agent session engine itself. Plotly Cloud is the louder track: since late May it has added viewer-seat pricing, domain verification, per-app compute modes with credit-metered billing, and customer-owned domains with managed TLS.

◆ Where it's heading

The Cloud releases are assembling the standard pieces of a hosting business in order — identity first (domain verification, explicitly framed as the step before SSO), then billing (viewer seats, then metered compute credits), and now production-grade serving (custom domains, automatic certificate renewal). Studio is being hardened as the authoring front end that feeds it: Universal Deployment pushed beyond Dash apps, credentials saved once and reused, a Winget channel to widen Windows installs, and in v0.0.86 a rebuilt session engine plus automatic retries so agent runs survive expired tokens. The two tracks converge on one funnel — author in Studio, deploy to Cloud, pay by compute consumed.

◆ Prediction

The Domain Verification entry names SSO as the next step and places it in the Enterprise tier, so single sign-on is the most likely Cloud release next. Studio should hold its one-to-two-week cadence, with the newly added app thumbnails pointing toward more work on browsing and organizing generated apps.

Alternatives to pharmaversesdtm and Plotly

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either pharmaversesdtm or Plotly.

See all pharmaversesdtm alternatives → · See all Plotly alternatives →

Recent activity from pharmaversesdtm and Plotly

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 14d agoPlotlyCustom Domains in Plotly Cloud
  2. 24d agoPlotlyPlotly Studio v0.0.85: Breadcrumbs & minor bug fixes
  3. 1mo agoPlotlyPlotly Studio v0.0.84: Faster AI, Saved Credentials, and Winget Support
  4. 1mo agoPlotlyCompute Modes and App Sizing in Plotly Cloud
  5. 1mo agoPlotlyPlotly Studio 0.0.83: Dash Update and macOS Fixes
  6. 1mo agopharmaversesdtmLymphoma response data and geographic-atrophy tests
  7. 2mo agoPlotlyPlotly Studio v0.0.82: Override for credential redaction, stability fixes
  8. 4mo agopharmaversesdtmCSV exports and microbiology domains for wider access
  9. 7mo agopharmaversesdtmNeurological SDTM datasets and Alzheimer's biomarkers
  10. 0y agopharmaversesdtmMaintainer and licensing update
  11. 1y agopharmaversesdtmMetabolic SDTM datasets and PCWG3 oncology response
  12. 1y agopharmaversesdtmGCIG response data and automated reference pages

Frequently asked questions

What is the difference between pharmaversesdtm and Plotly?

They serve adjacent needs but don't currently overlap on shipped themes. Plotly is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is pharmaversesdtm better than Plotly?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Plotly is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to pharmaversesdtm?

Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.

What are the best alternatives to Plotly?

Top Plotly alternatives in Analytics are ranked by recent ship velocity. Browse the "Plotly alternatives" section above for the current picks, or visit /alternatives/plotly for the full list with editorial commentary on each.